ResultsIQ

ResultsIQ › Latest results › Blue Star Limited

Blue Star Limited Q2 FY26 results deck summary

NSE: BLUESTARCO · BSE: 500067

Results deck of 6 Nov 2025, summarised by AI from the filing.

Q2 FY26 revenue ₹2422 cr (Q2 FY25: ₹2276 cr, +7.6%)

Key takeaways

  1. Revenue Q2 FY26 revenue ₹2422 cr (Q2 FY25: ₹2276 cr, +7.6%)
  2. Order book Projects order book ₹4,840 crore as of September 30, 2025
  3. MedTech moderation MedTech Solutions seeing moderation in revenue and profitability due to regulatory policy uncertainties

Original filing on BSE

Blue Star Limited Q1 FY27 results

As filed: Revenue ₹3,378 cr (+13% year on year), EBITDA ₹175 cr (−13% year on year), PAT ₹103 cr (−15% year on year), EBITDA margin 5.2% (−153 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹4,072 cr (+1% year on year), EBITDA ₹326 cr (+17% year on year), PAT ₹227 cr (+17% year on year), EBITDA margin 8.0% (+107 bps). Score 46 of 100, In line with trend. Revenue growth was well below the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin rose 107 bps year on year. Share price after the results: −12.4% in 30 days (Nifty 500: −2.9%).
  • Q3 FY26: Revenue ₹2,925 cr (+4% year on year), EBITDA ₹221 cr (+6% year on year), PAT ₹80.6 cr (−1% year on year), EBITDA margin 7.6% (+10 bps). Score 27 of 100, Below trend. Revenue growth was well below the company's own trend; EBITDA and profit before exceptional items growth were below it. EBITDA margin rose 10 bps year on year. Revenue rose ₹118 cr on a year ago, against ₹566 cr the year before. Share price after the results: +13.5% in 29 days (Nifty 500: +0.1%).
  • Q2 FY26: Revenue ₹2,422 cr (+6% year on year), EBITDA ₹183 cr (+24% year on year), PAT ₹99.0 cr (+3% year on year), EBITDA margin 7.6% (+105 bps). Score 44 of 100, In line with trend. Revenue growth was well below the company's own trend; EBITDA growth was in line with it; profit growth was below it. EBITDA margin rose 105 bps year on year. Revenue fell 19% from last quarter. Revenue rose ₹146 cr on a year ago, against ₹386 cr the year before. Share price after the results: −9.6% in 30 days (Nifty 500: +0.7%).
  • Q1 FY26: Revenue ₹2,982 cr (+4% year on year), EBITDA ₹200 cr (−16% year on year), PAT ₹121 cr (−28% year on year), EBITDA margin 6.7% (−160 bps). Score 13 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 160 bps year on year. Revenue fell 26% from last quarter. Revenue rose ₹117 cr on a year ago, against ₹639 cr the year before. Share price after the results: +9.8% in 30 days (Nifty 500: +0.7%).
  • Q4 FY25: Revenue ₹4,019 cr (+21% year on year), EBITDA ₹279 cr (+15% year on year), PAT ₹194 cr (+21% year on year), EBITDA margin 6.9% (−33 bps). Score 38 of 100, Below trend. Revenue and profit growth were below the company's own trend; EBITDA growth was well below it. EBITDA margin fell 33 bps year on year. Revenue rose ₹691 cr on a year ago, against ₹704 cr the year before. Share price after the results: −5.3% in 30 days (Nifty 500: +5.0%).
  • Q3 FY25: Revenue ₹2,807 cr (+25% year on year), EBITDA ₹209 cr (+36% year on year), PAT ₹132 cr (+32% year on year), EBITDA margin 7.5% (+57 bps). Score 54 of 100, In line with trend. Revenue and profit growth were in line with the company's own trend; EBITDA growth was below it. EBITDA margin rose 57 bps year on year. Revenue rose ₹566 cr on a year ago, more than the ₹453 cr it added the year before.
  • Q2 FY25: Revenue ₹2,276 cr (+20% year on year), EBITDA ₹148 cr (+20% year on year), PAT ₹96.0 cr (+35% year on year), EBITDA margin 6.5% (−1 bps). Score 68 of 100, Above trend. EBITDA margin was flat year on year. Not enough history for a trend yet: scored on growth alone. Revenue fell 21% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Blue Star Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.